According to a new report by Polaris Market Research, the global liquid biopsy for early cancer detection and monitoring market was valued at USD 2.18 billion in 2024 and is projected to reach USD 6.53 billion by 2034, expanding at a CAGR of 11.62% over the forecast period. Growth is underpinned by the rising global prevalence of cancer, expanding healthcare spending, and an active...